Results 101 to 110 of about 7,050 (179)

Development of High-Affinity CHD1 Chromodomain Inhibitors. [PDF]

J Med Chem
Greschik H, Friedrich F, Seifert L, Mousavizadeh F, Fiorentino F, Walz J, Zhang L, Li J, Fabbrizi E, Tomassi S, Panahi F, Papenkordt N, Wurnig SL, Osterroth J, Strasser AM, Ruprecht J, Moumbock AFA, Hügle M, Sum M, Peng L, Wang S, Baniahmad AA, Pulido-Cortés L, Timmers HTM, Flaig R, Metzger E, Breit B, Einsle O, Günther S, Rotili D, Mai A, Schüle R, Jung M.   +32 more
europepmc   +1 more source

The current status of quinazoline hybrids with antibreast cancer therapeutic potential-part II. [PDF]

Future Med Chem
Zeng H, Zhuang M, Cai F, Lin M, Wang R, Wang J, Zhang H.   +6 more
europepmc   +1 more source

Activity-based protein profiling guided new target identification of quinazoline derivatives for expediting bactericide discovery: Activity-based protein profiling derived new target discovery of antibacterial quinazolines. [PDF]

J Adv Res
Meng J, Zhang L, Tuo X, Ding Y, Chen K, Li M, Chen B, Long Q, Wang Z, Ouyang G, Zhou X, Yang S.   +11 more
europepmc   +1 more source

Advances in transition-metal catalyzed C-H bond activation of amidines to synthesize aza-heterocycles. [PDF]

RSC Adv
Ren J, Xiong Y, Li Q, Wang B, Wang G, Wang B, Liu H, Yang X.   +7 more
europepmc   +1 more source

Synthesis of 2-Aryl-4-aminoquinazolines: Design, Molecular Docking, and In Vitro Assessment of Antibacterial and Cytotoxic Potential. [PDF]

Int J Mol Sci
Verdugo F, Braillon C, Mahjoub S, Castro-Alvarez A, Janel-Bintz R, Fechter P, Villa P, Jiménez CA, Donoso-Ruiz DA, Pérez-Fehrmann M, Kesternich V, Ortiz S, Nelson R.   +12 more
europepmc   +1 more source

Quinazoline Derivatives as Targeted Chemotherapeutic Agents. [PDF]

Cureus
Zayed MF.
europepmc   +1 more source

The impact of EGFR-TKIs treatment on ground-glass opacity-featured lung adenocarcinama. [PDF]

J Cardiothorac Surg
Chen L, Yu T, Pan Y.
europepmc   +1 more source

Molecular docking, synthesis, and cytotoxic evaluation of novel quinazoline-quinazolinone hybrid compounds. [PDF]

Res Pharm Sci
Azarmi M, Rahimi S, Hormozi M, Rezaeinasab R.   +3 more
europepmc   +1 more source

Comparison of Peganum harmala L. leaves extract nanoformulations against herpes simplex virus type 1 guided by network pharmacology analysis. [PDF]

Sci Rep
Abou-Taleb BA, Elbanan AM, Hammoda HM, Abdelwahab IA, Mohyeldin MM, Ghallab DS.   +5 more
europepmc   +1 more source

Solvent-free and green synthesis of fused pyrimidine derivatives catalyzed by pillar[5]arene-based Lewis acid ionic liquid. [PDF]

Sci Rep
Rastegar S, Mohammadpoor-Baltork I, Asghari S, Tangestaninejad S, Moghadam M, Notash B.   +5 more
europepmc   +1 more source